Q2 2022 Holdings
Filed 2022-08-15 | 90 holdings | $51.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.9M | 139,212 | 25.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.3M | 211,495 | 16.1% |
| Alector Inc(ALEC) | COM | 014442107 | $5.6M | 552,438 | 10.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.8M | 187,717 | 9.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.0M | 475,367 | 7.7% |
| Atricure Inc(ATRC) | COM | 04963C209 | $2.9M | 72,029 | 5.7% |
| Axogen Inc(AXGN) | COM | 05463X106 | $2.7M | 332,103 | 5.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.2M | 131,200 | 4.3% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.8M | 941,800 | 3.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $1.6M | 136,935 | 3.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.4M | 496,150 | 2.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $810.0K | 74,890 | 1.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $771.0K | 313,600 | 1.5% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $597.0K | 351,064 | 1.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $525.0K | 198,094 | 1.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $154.0K | 40,796 | 0.3% |
| Spdr SP Biotech ETF(XBI) | ETF | 78464A870 | $45.5K | 613,000 | 0.1% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $25.2K | 13,680,554 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $16.0K | 110,100 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $13.7K | 935,766 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $13.7K | 550,940 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.3K | 438,623 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $13.2K | 261,280 | 0.0% |
| Ishares TR Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $12.1K | 102,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.1K | 82,655 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $7.9K | 62,053 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.6K | 548,561 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.2K | 566,695 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.1K | 370,987 | 0.0% |
| Merus N V | COM | N5749R100 | $6.0K | 262,891 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.8K | 299,785 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.8K | 180,306 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.5K | 695,959 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4K | 72,552 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.3K | 79,600 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.3K | 1,787,569 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $4.7K | 143,600 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.4K | 96,935 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $4.2K | 195,467 | 0.0% |
| Cardiovascular SYS Inc(CSIIEUR) | COM | 141619106 | $4.1K | 286,988 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.9K | $4,000,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $3.9K | 402,476 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $3.6K | 48,452 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.6K | 576,881 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $3.1K | 1,470,199 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $2.8K | 224,451 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6K | 265,663 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.5K | 766,774 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $2.4K | 156,904 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.4K | 42,675 | 0.0% |